Pfizer FDA Approval More Likely to Sway Black, Hispanic Holdouts
Mistrust has plagued the U.S. vaccination campaign, particularly among certain minority groups.
For many vaccine holdouts, Monday’s full regulatory approval from the Food and Drug Administration of the Pfizer Inc. and BioNTech SE shot is just the news they said they were waiting for to finally get inoculated. That’s particularly true, among Black and Hispanic people — two groups that still lag in vaccination rates across the U.S.
An update to a Kaiser Family Foundation survey from June shared with Bloomberg News found that among unvaccinated respondents, 46% of Hispanic and 41% of Black people said FDA approval would make them more likely to get a Covid-19 vaccine, compared to 25% of White people surveyed. Overall, KFF’s survey found that 31% of unvaccinated people said they were more likely to get vaccinated if the FDA gave full approval to vaccines. More than half of unvaccinated Black, Hispanic and White people said the “vaccine is too new” as a major reason for not getting the shot.